Abstract
A previously pilot study of treatment with transfer factor in 3 patients with juvenile rheumatoid arthritis (JRA) gave promising results. However, in this small and open study no definite conclusions could be drawn. Therefore, a double-blind group trial was performed in 12 JRA patients treated with transfer factor, and in 12 placebo-treated control patients. The patients were evaluated clinically, by laboratory tests, and by estimation of different lymphocyte populations and cell-mediated immunity in vitro and in vivo. Transfer factor was not found to be of significant therapeutic value in patients with JRA. The only statistically significant difference between the two groups was a greater reduction in the percentage of T lymphocytes in transfer factor-treated patients than in control patients. The significance of this is difficult to explain and could have appeared by chance. No side effects of treatment with transfer factor were noted.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amor, Brouihlet, Delbarre, Giroud, Kahan, Di Rosa, Velo, Turk, Willoughby, Timist New approaches to the evaluation of anti-rheumatic drugs. Agents Actions. 1974 Aug;4(3):169–172. doi: 10.1007/BF01970258. [DOI] [PubMed] [Google Scholar]
- Calabro J. J., Marchesano J. M. The early natural history of juvenile rheumatoid arthritis. A 10-year follow-up study of 100 cases. Med Clin North Am. 1968 May;52(3):567–591. [PubMed] [Google Scholar]
- Froland S. S., Natvig J. B., Hoyeraal H. M., Kåss E. The principle of immunopotentiation in treatment of rheumatoid arthritis: effect of transfer factor. Scand J Immunol. 1974;3(2):223–228. doi: 10.1111/j.1365-3083.1974.tb01252.x. [DOI] [PubMed] [Google Scholar]
- Froland S. S., Natvig J. B. Identification of three different human lymphocyte populations by surface markers. Transplant Rev. 1973;16:114–162. doi: 10.1111/j.1600-065x.1973.tb00119.x. [DOI] [PubMed] [Google Scholar]
- Gröhn P., Anttila R., Krohn K. The effect of non-specifically acting transfer factor component on cellular immunity in juvenile rheumatoid arthritis. Scand J Rheumatol. 1976;5(3):151–157. doi: 10.3109/03009747609165454. [DOI] [PubMed] [Google Scholar]
- Hoyeraal H. M., Froland S. S., Wisloff F. Lymphocyte populations and cellular immune reactions in juvenile rheumatoid arthritis. Scand J Immunol. 1975;4(8):801–810. [PubMed] [Google Scholar]
- Husby G., Blomhoff J. P., Skrede S., Elgjo K., Gjone E. Detection of immunoglobulins in paraffin-embedded liver biopsies. Studies in 100 patients with special regard to immunological findings in active chronic hepatitis. Scand J Gastroenterol. 1973;8(7):621–629. [PubMed] [Google Scholar]
- Kåss E., Froland S. S., Natvig J. B., Blichfeldt P., Hoyeraal H. M., Munthe E. A new principle of immunotherapy in rheumatoid arthritis: treatment with transfer factor. Scand J Rheumatol. 1974;3(3):113–117. doi: 10.3109/03009747409097134. [DOI] [PubMed] [Google Scholar]